Validation, in a Pediatric Population, of a French Translation of the MEPS/MEPI Score
Condition(s) studied
Investigational drug(s) / intervention(s)
MEPS-Fr version: The MEPS-Fr version will be tested on 120 patients treated either orthopedically or surgically for an elbow injury
Study summary
The MEPI (Modified Elbow Performance Index) or MEPS (Modified Elbow Performance Score) is a multidimensional assessment scale for elbow pain and function. This score is widely used in scientific literature, particularly for post-traumatic and post-operative evaluation, including in many French-language studies. However, no French translation of this score has undergone quality criteria verification and validation in a pediatric population.
Eligibility
Primary outcome measure(s)
- MEPS-FR score — day 0
Mayo Elbow Performance Score (MEPS) - MEPS-FR score — 6 weeks
Mayo Elbow Performance Score (MEPS) - MEPS-FR score — 12 weeks
Mayo Elbow Performance Score (MEPS) - PREE Score — day 0
The Patient-Rated Elbow Evaluation is PREE - PREE Score — 6 weeks
The Patient-Rated Elbow Evaluation is PREE - PREE Score — 12 weeks
The Patient-Rated Elbow Evaluation is PREE - quick DASH Score — day 0
DASH is Disabilities of the Arm, Shoulder and Hand - quick DASH Score — 6 weeks
DASH is Disabilities of the Arm, Shoulder and Hand - quick DASH Score — 12 weeks
DASH is Disabilities of the Arm, Shoulder and Hand
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| CHU Amiens | Amiens | France | Recruiting |
More Centre Hospitalier Universitaire, Amiens trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07624474 on ClinicalTrials.gov ↗ ← All trials in France